Company Profile
Applied Therapeutics Stock Price, News & Analysis
- Ticker:
- APLT
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for APLT.
Company overview
Business overview
Applied Therapeutics is a biotech company focused on rare disease, metabolic disease, and enzyme-related disorders. Its pipeline aims at diseases with clear biological mechanisms but high development difficulty.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Applied sits in specialty biotechnology.
Business Model Characteristics
The company depends on clinical data, regulatory steps, and the ability to convert niche biology into commercial value.
Position Within the Biotechnology Landscape
Applied Therapeutics is a high-catalyst rare-disease name with strong sensitivity to clinical outcomes.
Future catalysts
Applied Therapeutics’s catalysts are govorestat and the remaining rare-disease programs, where the next regulatory or clinical step will determine whether the story can still recover momentum. The company needs a clean path forward more than more broad promises.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Applied Therapeutics do?
Applied Therapeutics is a biotech company focused on rare disease, metabolic disease, and enzyme-related disorders. Its pipeline aims at diseases with clear biological mechanisms but high development difficulty.
On which exchange is APLT stock listed?
Applied Therapeutics (APLT) is associated with NASDAQ, United States, Biopharma.
What is govorestat?
Applied Therapeutics’s catalysts are govorestat and the remaining rare-disease programs, where the next regulatory or clinical step will determine whether the story can still recover momentum.
Which conditions is Applied Therapeutics targeting with govorestat?
Applied Therapeutics is associated with rare disease, metabolic disease based on its company overview and current catalyst commentary.
How does Applied Therapeutics describe recent progress with govorestat?
Applied Therapeutics’s catalysts are govorestat and the remaining rare-disease programs, where the next regulatory or clinical step will determine whether the story can still recover momentum.
What is Applied?
Applied Therapeutics is a biotech company focused on rare disease, metabolic disease, and enzyme-related disorders.
What should investors watch for with Applied?
Applied Therapeutics’s catalysts are govorestat and the remaining rare-disease programs, where the next regulatory or clinical step will determine whether the story can still recover momentum.
What is Therapeutics?
Applied Therapeutics is a biotech company focused on rare disease, metabolic disease, and enzyme-related disorders.